Pay to Marwadi

Company Profile

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC
BSE4697.504.7 (+0.1 % )
PREV CLOSE (Rs.) 4692.80
OPEN PRICE (Rs.) 4699.35
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 287
TODAY'S LOW / HIGH (Rs.)4646.00 4709.25
52 WK LOW / HIGH (Rs.)4595.85 5640
NSE4694.70 -5.8 (-0.12 % )
PREV CLOSE(Rs.) 4700.50
OPEN PRICE (Rs.) 4675.00
BID PRICE (QTY) 4694.70 (4 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 8445
TODAY'S LOW / HIGH(Rs.) 4642.55 4712.00
52 WK LOW / HIGH (Rs.)4575 5642.85

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 2.02
TTM EPS (Rs.) 136.54
P/E Ratio 34.40
Book Value (Rs.) 485.49
Face Value (Rs.) 10
MCap (Rs. in Mn) 77975.60
Price/Earning (TTM) 30.89
Price/Sales (TTM) 6.30
Price/Book (MRQ) 9.68
PAT Margin (%) 17.28
ROCE (%) 46.07
Incorporation Year : 1967

Management Info :

Suresh Talwar - Chairman Milind Thatte - Managing Director

Registered Office :

Address : Ground Floor And First Floor P & G Plaza,Cardinal Gracias Road,Chakala, Andheri (E),
Mumbai,
Maharashtra-400099

Phone : 022 68669000

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS More
27Mar03-27-2024$Procter & Gamble Hygiene and Health Care informs about disclosure Procter & Gamble Hygiene and
Procter & Gamble Hygiene and Health Care has informed that the Company has arrived at an advanced pricing agreement with the tax authorities on March 26, 2024, determining appropriate transfer pricing methodology for certain identified transactions with Company’s affiliate(s) for the years viz., F.Y. 2010-11 to F.Y. 2018-19. As a consequence of this agreement; 1. An additional tax liability, approximately of about Rs 36 crores (including interest) is payable. 2. There will be a reduction in contingent liabilities of approximately Rs 87 crores, subject to withdrawal of relevant tax litigations by the respective parties.

The above information is a part of company’s filings submitted to BSE.
Procter & Gamble Hygiene and Health Care has informed that..
04Mar03-04-2024$Procter & Gamble Health informs about loss of share certificates Procter & Gamble Health info

Procter & Gamble Health has informed that it has received information from its Registrars and Share Transfer Agents (RTA), KFin Technologies on March 1, 2024 regarding the loss /misplacement of the share certificate(s) as details enclosed. 

The above information is a part of company’s filings submitted to BSE.

Procter & Gamble Health has informed that it has received i..
06Feb02-06-2024$Procter & Gamble Health informs about corporate action Procter & Gamble Health info
Procter & Gamble Health has informed that the Board has approved interim dividend for Financial Year 2023-24 at its meeting held today. It has enclosed details regarding record date and payout of said dividend.

The above information is a part of company’s filings submitted to BSE.

Procter & Gamble Health has informed that the Board has app..
20Jan01-20-2024$Procter & Gamble Health informs about loss of share certificates Procter & Gamble Health info
Procter & Gamble Health has informed that it has been informed by its Registrars and Share Transfer Agents (RTA), KFin Technologies has informed regarding the loss /misplacement of the share certificate(s) as details enclosed.

The above information is a part of company’s filings submitted to BSE.

Procter & Gamble Health has informed that it has been infor..
21Dec12-21-2023$Procter & Gamble Health informs about loss of share certificate Procter & Gamble Health info
Procter & Gamble Health has informed that it received intimation from Registrars and Share Transfer Agents (RTA), KFin Technologies regarding the loss /misplacement of the share certificate(s) as enclosed.

The above information is a part of company’s filings submitted to BSE.

Procter & Gamble Health has informed that it received intim..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit720.72294.7
Gross Profit 997.2 3142
Operating Profit 1068.33430.7
Net Sales 3099.712296.2
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Bharat Parenterals (BSE)
 1455.20 (10.00%)
M.Cap ( in Cr)
846.88
Solara Active Pharma (BSE)
 551.45 (16.32%)
M.Cap ( in Cr)
1985.01
Abbott India (BSE)
 26131.85 (0.29%)
M.Cap ( in Cr)
55528.36
Windlas Biotech (BSE)
 555.05 (6.97%)
M.Cap ( in Cr)
1154.42
Concord Biotech (BSE)
 1595.25 (1.05%)
M.Cap ( in Cr)
16688.90
Shareholding Pattern More
MUTUAL FUNDS/UTI 9.86 %
PROMOTERS 51.82 %
FI/BANKS/INSURANCE 3.55 %
NON-INSTITUTION 28.21 %
GOVERNMENT 0 %
FII 0 %
F & O Quotes